24 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp03681 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | XTT test | L1210 | Not found | IC50 : 4.7 μM |
| dbacp03682 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | XTT test | CCRF-CEM T | Not found | IC50 : 5.0 μM |
| dbacp03683 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | XTT test | HL-60 | Not found | IC50 : 4.5 μM |
| dbacp03684 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | XTT test | HeLa S3 | Not found | IC50 : 8.4 μM |
| dbacp03685 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | MTT test | HeLa S3 | Not found | IC50 : 5.0 μM |
| dbacp03686 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | MTT test | PC12 | Not found | IC50 : 10.0 μM |
| dbacp03687 | Lasioglossin LL-III | VNWKKILGKIIKVVK | Broad-faced Furrow Bee | Cell membrane disintegration | MTT test | SW480 | Not found | IC50 : 15.0 μM |
| dbacp03688 | Lasioglossin LL-III | VNWKKILGKIIKVVK | The Eusocial Bee, Broad-faced Furrow Bee | Disruption of cell membrane | Not specified | Not found | Not specified | LC50 : > 200 µM |
| dbacp03689 | Lasioglossin LL-III | VNWKKILGKIIKVVK | The Eusocial Bee, Broad-faced Furrow Bee | Disruption of cell membrane | Not specified | Not found | Not specified | Not found |
| dbacp04180 | LL-III | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | HeLa | Cervical cancer | IC50 : 4 ± 1 µM |
| dbacp04181 | LL-III | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 18 ±4 µM |
| dbacp04182 | LL-III | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | CCRF-CEM | Leukemia cancer | IC50 : 5 ± 3 µM |
| dbacp04192 | LL-III/12 | vnwkkilgkiikvvk | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | HeLa | Cervical cancer | IC50 : 6 ± 2 µM |
| dbacp04193 | LL-III/12 | vnwkkilgkiikvvk | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 20 µM |
| dbacp04194 | LL-III/12 | vnwkkilgkiikvvk | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | CCRF-CEM | Leukemia cancer | IC50 : 5 ± 2 µM |
| dbacp04240 | LL-III/37 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 5 ± 1 µM |
| dbacp04241 | LL-III/37 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 13 µM |
| dbacp04242 | LL-III/37 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | CCRF-CEM | Leukemia cancer | IC50 : 4 ± 1 µM |
| dbacp04249 | LL-III/8 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | HeLa | Cervical cancer | IC50 : 12 ± 1 µM |
| dbacp04250 | LL-III/8 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | Not found |
| dbacp04251 | LL-III/8 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | CCRF-CEM | Leukemia cancer | IC50 : 9 µM |
| dbacp04252 | LL-III/9 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | HeLa | Cervical cancer | IC50 : 3 ± 1 µM |
| dbacp04253 | LL-III/9 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | SW | Colon cancer | IC50 : 25 ± 5 µM |
| dbacp04254 | LL-III/9 | VNWKKILGKIIKVVK | Lasioglossin III and its analogs | Cell membrane damage | MTT/MTS assay | CCRF-CEM | Leukemia cancer | Not found |